Epithelial proliferation in inflammatory skin disease is regulated by tetratricopeptide repeat domain 7 (Ttc7) in fibroblasts and lymphocytes - 04/01/19

Abstract |
Background |
Mutations in tetratricopeptide repeat domain 7A (TTC7A) and its mouse orthologue, Ttc7, result in a multisystemic disease, mostly affecting the epithelial barriers and immune system. Despite successful hematopoietic stem cell transplantation, ongoing progression of gastrointestinal manifestations can be life-threatening in TTC7A-deficient patients.
Objective |
We sought to identify whether TTC7A mutations dysregulate epithelial cells only or whether a cell-intrinsic defect in lymphocytes or other cells contributes to disease manifestations.
Methods |
Ttc7-mutated (Ttc7fsn/fsn) mice were crossed to generate double-mutant (Rag2−/−Ttc7fsn/fsn) and triple-mutant (Rag2−/−IL2rg−/−Ttc7fsn/fsn) mice. These models, together with bone marrow chimeras, were used to explore the role of adaptive and innate lymphocytes in the flaky skin phenotype. The effect of the Ttc7fsn/fsn mutation on stromal cells was tested in a xenograft model in conjunction with transcriptomic analysis of Ttc7fsn/fsn fibroblasts.
Results |
We observed that the severity of epithelial hyperproliferation was accentuated by lymphocytes, whereas the phenotype was not induced by transfer of Ttc7-mutated hematopoietic cells. Furthermore, mice completely lacking the lymphocytic compartment were not protected from epithelial hyperproliferation. Ttc7-mutated mouse fibroblasts expressed increased transcript levels of insulin-like growth factor 1 (Igf1) and the antimicrobial protein regenerating islet-derived protein 3γ (Reg3γ). In a xenograft model Ttc7-mutated fibroblasts markedly increased epithelial proliferation of keratinocytes. Thus Ttc7-mutated fibroblasts were identified as potent instigators of epithelial hyperproliferation.
Conclusion |
Our results reveal a previously unsuspected fundamental cell-extrinsic role of Ttc7. We have identified potential candidates for molecularly targeted treatment strategies that will need to be evaluated in future preclinical studies.
Le texte complet de cet article est disponible en PDF.Key words : Primary immunodeficiency, TTC7A mutation, fibroblasts, psoriasis, mouse model
Abbreviations used : APC, DESS, DMEM, FITC, fsn, GO, HSCT, Igf1, ILC, NGS, PE, qPCR, Reg3γ, STAT3, TLR, TTC7A, WT
Plan
| U.N. and J.P.S. were funded by grants from the Forschungskredit program of the University of Zurich, the Olga Mayenfisch and the Herzog Egli Stiftung, Zurich, Switzerland. A.A.M., B.V., and J.P.S. were funded by the Hochspezialisierte Medizin Schwerpunkt Immunologie; A.M. was funded by the Ulrich Müller-Gierok Foundation, Bern, Switzerland and the Forschungskredit program of the University of Zurich; B.V. and J.P.S. were funded by the Helmut Horten Foundation; S.V. was funded by the Heidi Ras Foundation and the Rare Disease Initiative Zurich (radiz); and J.P.S. received a grant from the Swiss National Science Foundation's Ambizione program (reference PZ00P3_136632). |
|
| Disclosure of potential conflict of interest: J. Pachlopnik Schmid has received consultancy fees from Novartis and research support from the Helmut Horten Foundation, the Forschungskredit program of the University of Zurich, the Olga Mayenfisch, EMDO, and Herzog Egli Stiftung, the Hochspezialisierte Medizin Schwerpunkt Immunologie, Ulrich Müller-Gierok Foundation, and the Swiss National Science Foundation; is employed by the University of Zurich, Switzerland, and University Children's Hospital Zurich; and has received lecture fees from the Kinderärzte Schweiz and the University of Zurich. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 143 - N° 1
P. 292 - janvier 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
